Open Menu Close Menu

MDA Venture Philanthropy (MVP) is MDA’s drug development arm. MVP acts within MDA’s Translational Research Program, and has the mission of identifying and overcoming the inherent regulatory, cultural, financial and logistical barriers to bringing to market new therapeutic agents for neuromuscular disease. Proposed MVP projects must move a potential therapeutic agent closer to the market, and have a plan to make it commercially available (directly or indirectly).